Prince of Wales Hospital — Randwick, New South Wales

Public research footprint of Prince of Wales Hospital, compiled from the ClinicalTrials.gov public registry.

215

Registered studies

Active

Recruiting now

112

Completed

Stopped or withdrawn

Most-studied conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Low Grade Serous Ovarian Cancer · Relapsed Refractory Multiple Myeloma (RRMM) · Recurrent Endometrial Cancer

Recently updated registry entries

NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT03748641 — A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus… (Active Not Recruiting)
NCT06072781 — A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Prince of Wales Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.